Fulcrum Therapeutics Inc (FULC) — Cash Flow Quality Index
Latest as of June 2024:
1.06x
Fulcrum Therapeutics Inc (FULC) has a Cash Flow Quality Index of 1.06x as of June 2024. Operating cash flow of $58.90 Million exceeds net income of $55.41 Million, indicating high earnings quality where cash backs reported profits. Also explore FULC current and non-current assets for the complete picture of this company's asset base.
Cash Flow Quality Index
1.06x
Operating CF / Net Income
Operating Cash Flow
$58.90 Million
USD
Net Income
$55.41 Million
USD
Data as of
Jun 2024
Most recent filing
Annual Cash Flow Quality Index for Fulcrum Therapeutics Inc (None–None)
Year-by-year earnings quality comparison for Fulcrum Therapeutics Inc. For live market cap and the full company financial profile, see FULC stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.